2025. COMPARISON OF EFFICACY OF FIXED-DOSE ROSUVASTATIN PLUS EZETIMIBE COMBINATION THERAPY VERSUS ROSUVASTATIN MONOTHERAPY IN CORONARY ARTERY DISEASE PATIENTS. The Research of Medical Science Review. 3, 8 (Aug. 2025), 539–545.